Pharmacological inhibition of FABP4 activity by a highly selective inhibitor BMS309403 (Figure 1; Furuhashi et al., 2007) resulted in ameliorating renal structural damage, improving renal function and reducing ER stress of tubular cells in mice of I/R-induced AKI. Here, FABP4 is linked to acute kidney injury.